Latest Breaking News On - Germline companion diagnostic test - Page 5 : comparemela.com

Myriad Genetics (NASDAQ:MYGN) Updates FY24 Earnings Guidance

Myriad Genetics (NASDAQ:MYGN) Updates FY24 Earnings Guidance
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerWells fargo companyVanguard group incGroup plcWolfe researchGoldman sachs groupPricet rowe associates incGenetics incBarclays plcGenetics company profileVoloridge investment managementMyriad geneticsGet free reportGenetics trading downGeneral group plc

Myriad Genetics (NASDAQ:MYGN) Issues FY24 Earnings Guidance

Myriad Genetics (NASDAQ:MYGN) Issues FY24 Earnings Guidance
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerCresset asset managementWells fargo companyRoyal bankGoldman sachs groupAmeritas investment partners incPricet rowe associates incUs bancorpGenetics incGenetics company profileJpmorgan chase coMyriad geneticsGet free reportAsset managementAmeritas investment partners

Myriad Genetics (MYGN) to Release Quarterly Earnings on Tuesday

Myriad Genetics (MYGN) to Release Quarterly Earnings on Tuesday
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerBarclays plcVanguard group incWells fargo companyVoloridge investment managementGoldman sachs groupGenetics company profileJpmorgan chase coPricet rowe associates incGenetics incGroup plcMyriad geneticsGet free reportGeneral group plcMyrisk hereditary cancer test

Myriad Genetics, Inc (NASDAQ:MYGN) Given Average Rating of Hold by Brokerages

Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) has been assigned a consensus rating of “Hold” from the eight research firms that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating on […]

Hong kongUnited statesPiper sandlerGoldman sachs groupChina universal asset management coJpmorgan chase coTower research capitalRoyal bankGenetics incHong kong ltdWolfe researchMyriad geneticsGet free reportMarketbeat ratingsUniversal asset managementKong ltd

Myriad Genetics (NASDAQ:MYGN) PT Raised to $31 00 at The Goldman Sachs Group

Myriad Genetics (NASDAQ:MYGN – Get Free Report) had its price objective boosted by research analysts at The Goldman Sachs Group from $28.00 to $31.00 in a research report issued on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. The Goldman Sachs Group’s target price would suggest a potential upside of […]

United statesPiper sandlerUs bancorpWolfe researchProshare advisorsPricet rowe associates incGenetics incRoyal bankGoldman sachs groupAmeritas investment partners incWells fargo companyMyriad geneticsGet free reportInvestment partnersShare advisorsMyrisk hereditary cancer test